Does Revolution Medicines’ pancreatic cancer drug have even greater potential? - Top-Institutions - MDSpire

Does Revolution Medicines’ pancreatic cancer drug have even greater potential?

  • By

  • Adam Feuerstein

  • June 4, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of California, Los Angeles (UCLA) Health
    University of California, Los Angeles (UCLA) Health

    Los Angeles, California

    Key Differentiators

    • Oncology

  • #2

    American Society of Clinical Oncology
    American Society of Clinical Oncology

    Alexandria, Virginia

    Key Differentiators

    • Oncology

  • #3

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

Original Source(s)

Does Revolution Medicines’ pancreatic cancer drug have even greater potential?

  • by Adam Feuerstein

  • June 4, 2026

Related Content

LUCAT1 promotes stemness in head and neck squamous cell carcinoma by sponging miR-128

Advancing Gastrointestinal Cancer Risk Prediction With Patient-Centered Machine Learning: Machine Learning Modeling Study

Tumor safety of biologic agents and targeted therapies in immune-mediated inflammatory arthritides